Group psychoeducational intervention program for family caregivers of people with dementia: a pilot randomized control trial in Chile

Not Applicable

Completed

• Conditions: Mental health and quality of life of family caregivers of people with dementia; Mental and Behavioural Disorders

• Registration Number: ISRCTN15218542
• Lead Sponsor: ational Agency for Research and Development

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-10-02
• Study Start: 2022-05-08
• Last Update Posted: 16 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 73

Inclusion Criteria

1. Being a relative of the person with dementia
2. Directly caring for the person with dementia at least three times a week
3. Not receiving financial compensation associated with care

Exclusion Criteria

Caregivers with a severe physical or psychiatric problem that might prevent them from attending the sessions of the psychoeducational program and/or responding to the battery of instruments

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> All primary outcomes were assessed at baseline and at the end of the intervention:<br> 1. Dysfunctional thoughts about caregiving measured using the Dysfunctional Thoughts Questionnaire<br> 2. Frequency of pleasant activities measured using the Questionnaire of Satisfaction with Free time<br> 3. Quality of life measured using the EuroQoL- 5 Dimensions (EQ-5D)<br>

Secondary Outcome Measures

Name	Time	Method
<br> All secondary outcomes were assessed at baseline and at the end of the intervention:<br><br> For the family caregiver:<br> 1. Anxiety and depression measured using the Hospital Anxiety and Depression Scale<br> 2. Level of burden experienced by family caregivers measured using the Caregiver Burden Scale<br><br> For the person with dementia:<br> 1. Severity of dementia measured using the Clinical Dementia Rating (CDR)<br> 2. Quality of life measured using the Quality of Life Scale in Alzheimer's Disease (QoL-AD)<br> 3. Functionality measured using the Technology-Activities of Daily Living Questionnaire (T-ADLQ)<br> 4. Behavioural and psychological symptoms measured using the Neuropsychiatric Inventory (NPI-Q)<br>